Core Insights - OptimizeRx reported strong fiscal 2025 results, with revenue of $109.4 million and adjusted EBITDA of $24.3 million, exceeding both internal expectations and consensus estimates [2][5] - The company experienced growth from established customers and increased contributions from mid-tier and long-tail life sciences companies [2][14] - Management updated the 2026 outlook, anticipating revenue of $109–114 million and adjusted EBITDA of $21–25 million, citing early-year softness in contracted revenue due to shifting customer spending patterns [4][19] Financial Performance - For Q4 2025, OptimizeRx achieved revenue of $32.2 million and adjusted EBITDA of $12.0 million, with a gross margin of 74.8%, up from 68.1% in the previous year [5][6] - Net income for Q4 was $5.0 million, or $0.26 per fully diluted share, compared to a net loss of $0.1 million in Q4 2024 [7] - Operating cash flow for 2025 was $18.7 million, significantly higher than $4.9 million in 2024, with cash and short-term investments rising to $23.4 million from $13.4 million [8] Strategic Initiatives - The board authorized a $10 million share repurchase program while prioritizing debt paydown, with current debt at $26.3 million [3][13] - Management highlighted the potential of artificial intelligence as a commercial tailwind, suggesting it could enhance efficiency in marketing budgets and channel partner distribution [16] - The company is focusing on expanding point-of-prescribe connectivity and integrating with EHR systems to improve workflow embedding [17] Market Dynamics - Management noted a market shift away from managed services, which contributed approximately $9 million in the first half of 2025, leading to a more conservative spending tone among clients [9][10] - Contracted revenue, excluding managed services, is running 15% to 20% behind normal expectations due to shorter contract durations [12] - Average revenue per top 20 pharmaceutical manufacturer decreased to $2.8 million from $3.0 million in 2024, attributed to lower buy-ups and data-related revenue [15]